Sign Up
NEWSROOM
We are data-driven and are focused on contributing to research and treatments for unmet medical needs
Recent News
May 05, 2025
Read More
Apr 16, 2025
Apr 14, 2025
2025
All News
05
May
INmune Bio Inc. to Report First Quarter 2025 Financial Results and Provide Corporate Update on Thurs...
16
Apr
INmune Bio Receives Favorable Patentability Opinion for CORDStrom™ Platform Technology...
14
INmune Bio Partners with Cell and Gene Therapy Catapult to Scale Up CORDStrom™ Manufacturing for C...
01
INmune Bio Inc. Presents Baseline Demographics and Disease Profiles of Participants in the MINDFuL P...
27
Mar
INmune Bio Inc. Announces Year End 2024 Results and Provides a Business Update...
24
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on Marc...
12
Feb
INmune Bio Opens Phase II in High Dose Cohort of INKmune™ Trial in Prostate Cancer...
10
INmune Bio Announces Plan to Submit FDA Biologics License Application (BLA) Seeking Approval of CORD...
28
Jan
INmune Bio Inc. Expands INKmune Trial in Prostate Cancer to Veterans...
Subscribe to receive the latest updates